MAPK4 and central nervous system cancer: GSEA also showed that signaling pathways (MAPK, PI3K, Focal_adhesion‐PI3K/AKT/mTOR and EGFR) were significantly enriched in gliomas with high MAPK4 expression (Figure 8A).